This was discussed in the press several weeks back, there was a Downing Street briefing that day about it - they hammered home two points
1) The data isn't in on severe disease and hospitalization - and they strongly suspect that it will still have a positive impact on that
2) B1351 is not our dominant strain (in the UK and elsewhere) and since it's not more infectious than our already very infectious strain, probably won't be
1) The data isn't in on severe disease and hospitalization - and they strongly suspect that it will still have a positive impact on that
2) B1351 is not our dominant strain (in the UK and elsewhere) and since it's not more infectious than our already very infectious strain, probably won't be